Skip to main content
. 2015 Oct 29;6:248. doi: 10.3389/fphar.2015.00248

Table 1.

Energetic contribution to PyDock score.

Complex Electrostatic energy (kcal/mol) Desolvation energy (kcal/mol) VdW (kcal/mol) RMSD (nm)
Ranibizumab/VEGFA −7 −24 −76 0.05 vs. 1CZ8
Fab-bevacizumab/VEGFA −8 −20 −62 0.05 vs. 1BJ1
*VEGFR1d2_R2d3/VEGFA −22 −9 19 0.30 vs. 2X1W 0.20 vs. 3V2A
**VEGFR1d2_R2d3/VEGFA −11 −12 34 0.40 vs. 2X1W 0.50 vs. 3V2A

VdW (Van der Waals interaction energy), RMSD (root-mean-square deviation).

*

Aflibercept binding domain optimized with MD.

**

Aflibercept binding domain without structural optimization.